SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-163723
Filing Date
2013-04-22
Accepted
2013-04-22 06:09:36
Documents
4
Period of Report
2013-05-29
Effectiveness Date
2013-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d520152ddef14a.htm DEF 14A 507717
2 GRAPHIC g520152g04l47.jpg GRAPHIC 15191
3 GRAPHIC g520152g25m01.jpg GRAPHIC 5891
4 GRAPHIC g520152g32o00.jpg GRAPHIC 7419
  Complete submission text file 0001193125-13-163723.txt   548504
Mailing Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-745-7802
HYPERION THERAPEUTICS INC (Filer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35614 | Film No.: 13772664
SIC: 2834 Pharmaceutical Preparations